Doctors can use either an artery in the arm (the radial approach) or in the groin (the femoral approach) to safely perform percutaneous coronary intervention (PCI) on patients presenting with a heart attack, according to research presented at the American College of Cardiology’s 68th Annual Scientific Session. The research, which was stopped early, suggests the […]Continue Reading ...
In a study published today in the Journal of Experimental Medicine, researchers successfully used a new approach that significantly minimized brain damage caused by stroke in mouse models. The new approach works by targeting hemichannels—pathways that allow for the flow of chemical ions and small molecules—that are expressed by astrocytes, cells that play a protective […]Continue Reading ...
Many new anti-cancer drugs inhibit proteins that are essential for the proliferation of cancer cells. One example is ibrutinib, an innovative therapy for chronic lymphocytic leukemia first approved in 2014. Chronic lymphocytic leukemia is caused by uncontrolled growth of cells from the body’s immune system. It is the most common leukemia in the Western world. […]Continue Reading ...
Jan 18 2019 SP Scientific has launched a microsite dedicated to its new Line of Sight (TM) approach, a breakthrough suite of freeze-drying equipment with scalable lyophilization and process analytical tools (PAT). The goal of Line of Sight is to bring pharmaceutical products safely and quickly to market by enhancing product and process knowledge at […]Continue Reading ...
At the 96th General Session of the International Association for Dental Research (IADR), held in conjunction with the IADR Pan European Regional (PER) Congress, Jesse Jokerst, University of California, San Diego, USA gave an oral presentation titled “Non-Invasive, Ultrasound-based Approach for Pocket Depth Measurements.” The IADR/PER General Session & Exhibition is in London, England at […]Continue Reading ...
July 24, 2018 A major factor underlying Parkinson’s Disease (PD) pathology is the loss of dopamine neurons in the substantia nigra, and thus current therapies often aim to restore dopamine signaling. However, these treatments are not curative. The most promising approach for truly reversing disease progress involves the replacement of the specific dopamine neurons that […]Continue Reading ...
June 21, 2018 A new therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB). Neurodegeneration in this condition results from the abnormal accumulation of essential cellular molecules called mucopolysaccharides. Looking to find alternative therapeutic strategies for this rare genetic disease, a team of researchers investigated whether enhancing the […]Continue Reading ...
A new approach to information gathering could allow scientists to quickly identify the most effective way to manage a disease outbreak, an advance that could save lives.Continue Reading ...
Immune checkpoint inhibitors, such as the anti-PD-1 antibody pembrolizumab, have become important tools for managing non-small-cell lung cancer (NSCLC). Assessing the level of programmed death ligand 1 (PD-L1) expressed by a tumor can help clinicians determine how the patient should be treated. A report in The Journal of Molecular Diagnostics describes a novel and rapid […]Continue Reading ...
In the late 1950s, the treatment for fractures involved three to four months in hospital in plaster-casts and traction. Recovery was slow, and up to 70 percent of patients experienced reduced mobility upon recovery. Leading a Surgical Revolution: The AO Foundation-Social Entrepreneurs in the Treatment of Bone Trauma, tells the story of a group of […]Continue Reading ...
Jan 18 2019 A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an Essay published January 15 in the open-access journal PLOS Medicine by Mark Tenforde of the University of Washington School of Medicine, and […]Continue Reading ...
Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to massively reduce the impact of deadly diseases such as Ebola, Marburg and Lassa fever. Researchers from the University of Cambridge will shortly begin clinical trials of a new vaccine that builds on almost […]Continue Reading ...
June 26, 2018 A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer–including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. In 2017, researchers […]Continue Reading ...
May 15, 2018 In the treatment of cancer, there are still several limitations. Especially the delivery of sufficient amounts of active chemotherapeutic drug is difficult. After the conventional intravenous administration, the therapeutic formulation faces some hurdles before reaching the target site. In most cases, the blood circulation time of the active compound is rather short, […]Continue Reading ...
April 17, 2017 Chemists at The Scripps Analysis Institute (TSRI) have advanced a huge and strikingly simple approach for synthesizing a category of molecules that experience demonstrated worth as prescribed drugs. The trouble of getting ready those compounds—boronic acids and intently similar molecules referred to as boronate esters—has a great deal restricted their use within […]Continue Reading ...
- New nanotechnology approach shows promise in treating triple negative breast cancer
- Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
- Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
- Apple watch could detect irregular heart beat says study
- Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
- Girls should be encouraged to gain more ball skills, shows study
- Acute doses of synthetic cannabinoid can impair critical thinking and memory
- Presence of bacteria in urine does not always point to infection, shows study
- Scientists identify a new role for nerve-supporting cells
- Hidden differences between pathology of CTE and Alzheimer’s disease discovered
- Knowing causative genes of osteoporosis may open door to more effective treatments
- Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
- New model for intensive care identifies factors that send ill patients to ICU
- Recommendations Issued for HSCT in Multiple Myeloma
- Deep brain stimulation provides sustained relief for severe depression
- “Statistical significance” may soon be a thing of past?
- Researchers track effects of epigenetic marks carried by sperm chromosomes
- AHA News: Family Adopts Three Children With Three Different Heart Conditions
- Research into opioid painkillers could provide clues for safer drug development
- Lung cancer survivor recounts her lifetime struggles